We are improving our search experience. To check which content you have full access to, or for advanced search, go back to the old search.

Search

Please fill in this field.

Search Results

Showing 1-20 of 1,177 results
  1. Fenfluramine for the Treatment of Dravet Syndrome and Lennox Gastaut Syndrome: A Review

    Purpose of Review

    Treatment-resistant epilepsy comprises approximately 36.3% of neurology clinic-based populations in the USA. Despite new drug...

    Douglas R. Nordli III, Fernando N. Galan in Current Treatment Options in Neurology
    Article 24 September 2022
  2. Fenfluramine for the treatment of status epilepticus: use in an adult with Lennox–Gastaut syndrome and literature review

    Background

    Novel treatments are needed to control refractory status epilepticus (SE). This study aimed to assess the potential effectiveness of...

    Adam Strzelczyk, Hendrik Becker, ... Catrin Mann in Neurological Research and Practice
    Article Open access 22 February 2024
  3. A survey of preferences and expectations for surgical interventions targeting atonic seizures in Lennox-Gastaut syndrome

    Purpose

    To assess preferences and outcome expectations for vagus nerve stimulation (VNS) and corpus callosotomy (CC) surgeries in the treatment of...

    Evelyn Pan, Martin G. Piazza, ... Taylor J. Abel in Child's Nervous System
    Article 08 May 2024
  4. The burden of illness in Lennox–Gastaut syndrome: a systematic literature review

    Background

    Lennox–Gastaut syndrome (LGS) is a severe developmental and epileptic encephalopathy characterized by drug-resistant epilepsy with multiple...

    Adam Strzelczyk, Sameer M. Zuberi, ... Susanne Schubert-Bast in Orphanet Journal of Rare Diseases
    Article Open access 01 March 2023
  5. Fenfluramine: A Review in Dravet and Lennox-Gastaut Syndromes

    Fenfluramine (Fintepla ® ) is an oral anti-seizure medication (ASM) with a novel mechanism of action consisting of activity in the serotonergic system...

    James E. Frampton in Drugs
    Article Open access 15 June 2023
  6. Fenfluramine in clinical practice: new therapy option for Dravet and Lennox–Gastaut syndromes

    Fenfluramine is an antiseizure medication for the treatment of Dravet and Lennox–Gastaut syndromes. This review summarizes the literature on the...

    Hiltrud Muhle, Gerhard Kurlemann, ... Milka Pringsheim in Clinical Epileptology
    Article Open access 03 January 2024
  7. Comorbidities in Dravet Syndrome and Lennox–Gastaut Syndrome

    This study aims to describe the main cognitive and behavioral comorbidities of Dravet syndrome (DS) and Lennox–Gastaut syndrome (LGS), their impact...

    Francesca Marchese, Simona Cappelletti, ... Pasquale Striano in SN Comprehensive Clinical Medicine
    Article Open access 16 June 2021
  8. Efficacy analysis of oral dexamethasone in the treatment of infantile spasms and infantile spasms related Lennox–Gastaut syndrome

    Objective

    Treatment with adrenocorticotropic hormone (ACTH) or a corticosteroid is the first choice for infantile spasms (IS), and vigabatrin is the...

    Jieling Li, Yu**g Gao, ... **uquan Zhai in BMC Pediatrics
    Article Open access 23 May 2023
  9. Development of localized interictal epileptiform discharges following vagus nerve stimulation for lennox-gastaut syndrome: a case report

    Background

    Lennox-gastaut syndrome (LGS) is an epileptic encephalopathy often associated with behavioral and psychiatric disorders. Vagus nerve...

    Renli Qi, Wei Wang, ... Hualin Yu in Acta Epileptologica
    Article Open access 07 December 2022
  10. Truncating mutation in TANC2 in a Chinese boy associated with Lennox-Gastaut syndrome: a case report

    Background

    Lennox-Gastaut syndrome (LGS) is a severe epileptic encephalopathy that can be caused by brain malformations or genetic mutations....

    Yang Tian, Zhen Shi, ... Wen-**ong Chen in BMC Pediatrics
    Article Open access 03 December 2021
  11. Lennox–Gastaut Syndrome: Perspective of a Parent and a Physician

    This article is co-authored by a parent of a 32-year-old male patient with Lennox–Gastaut syndrome (LGS) and his epileptologist. It discusses the...

    Heather R. McKee, Barbara Glasgow in Neurology and Therapy
    Article Open access 28 October 2020
  12. Kallosotomie bei Lennox-Gastaut-Syndrom

    Corpus callosotomy is a palliative therapy option in patients with drop attacks or therapy-resistant bilateral tonic-clonic seizures (BTCS),...

    Susanne Fauser, Christian G. Bien, Anna Rada in Zeitschrift für Epileptologie
    Article 17 May 2022
  13. Correction to: Comorbidities in Dravet Syndrome and Lennox–Gastaut Syndrome

    Francesca Marchese, Simona Cappelletti, ... Pasquale Striano in SN Comprehensive Clinical Medicine
    Article Open access 19 October 2021
  14. Clinical Trial Outcome Measurements in Lennox-Gastaut Syndrome and Their Application to the Development of Targeted Treatments

    Purpose of Review

    Lennox-Gastaut syndrome (LGS) is an epileptic encephalopathy that is challenging to treat, with >80% of patients remaining...

    Victoria Danan, Patel Anup, ... Jacqueline S Gofshteyn in Current Treatment Options in Neurology
    Article 09 September 2021
  15. Highly Purified Cannabidiol for Epilepsy Treatment: A Systematic Review of Epileptic Conditions Beyond Dravet Syndrome and Lennox–Gastaut Syndrome

    Background

    Cannabidiol (CBD), which is one major constituent of the Cannabis sativa plant, has anti-seizure properties and does not produce euphoric...

    Simona Lattanzi, Eugen Trinka, ... Francesco Brigo in CNS Drugs
    Article Open access 22 March 2021
  16. Lennox-Gastaut-Syndrom: Wie behandeln?

    The Lennox-Gastaut syndrome (LGS) is a rare and age-dependent epileptic encephalopathy and is difficult to treat. It presents with variable seizure...

    Article 01 February 2021
  17. Expanding the Treatment Landscape for Lennox-Gastaut Syndrome: Current and Future Strategies

    Lennox-Gastaut syndrome (LGS), a childhood-onset severe developmental and epileptic encephalopathy (DEE), is an entity that encompasses a...

    Adam Strzelczyk, Susanne Schubert-Bast in CNS Drugs
    Article Open access 21 January 2021
  18. Fenfluramine for the Treatment of Dravet Syndrome and Lennox–Gastaut Syndrome

    The last 50 years has seen the introduction of a great number of antiepileptic drugs, relieving the burden of seizures for many patients. However,...

    Ganna Balagura, Marta Cacciatore, ... Alberto Verrotti in CNS Drugs
    Article 01 September 2020
  19. Efficacy and safety of corpus callosotomy and ketogenic diet in children with Lennox Gastaut syndrome: a systematic review and meta-analysis

    Background

    Both corpus callosotomy (CC) and the ketogenic diet (KD) are commonly used in patients with Lennox Gastaut syndrome (LGS), as a significant...

    Indar Kumar Sharawat, Prateek Kumar Panda, ... Lesa Dawman in Child's Nervous System
    Article 19 April 2021
  20. Epilepsy and other comorbidities in Down syndrome

    Down syndrome (DS) is the most common cause of intellectual disability. Due to many genetic and biochemical aberrations, people with DS suffer from...

    Frank Bösebeck in Zeitschrift für Epileptologie
    Article Open access 15 June 2022
Did you find what you were looking for? Share feedback.